News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
McKesson Corporation Pays $350 Million in Settlement That Lowers Drug Prices 4 Percent
March 27, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BNET -- The prices of about 1,400 branded drugs are about to get a little cheaper because of a $352.7 million class action settlement with wholesale drug distributor McKesson.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Tariffs
Rare Disease, Cell and Gene Therapy at Risk From Trump Tariffs, Industry Says
June 3, 2025
·
4 min read
·
Annalee Armstrong
Government
Fake Citations Plague RFK Jr.’s MAHA Report
May 30, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
May 29, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs
May 28, 2025
·
2 min read
·
Annalee Armstrong